Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase. 2014

Yibing Shan, and Kavitha Gnanasambandan, and Daniela Ungureanu, and Eric T Kim, and Henrik Hammarén, and Kazuo Yamashita, and Olli Silvennoinen, and David E Shaw, and Stevan R Hubbard
1] D. E. Shaw Research, New York, New York, USA. [2].

Janus kinase-2 (JAK2) mediates signaling by various cytokines, including erythropoietin and growth hormone. JAK2 possesses tandem pseudokinase and tyrosine-kinase domains. Mutations in the pseudokinase domain are causally linked to myeloproliferative neoplasms (MPNs) in humans. The structure of the JAK2 tandem kinase domains is unknown, and therefore the molecular bases for pseudokinase-mediated autoinhibition and pathogenic activation remain obscure. Using molecular dynamics simulations of protein-protein docking, we produced a structural model for the autoinhibitory interaction between the JAK2 pseudokinase and kinase domains. A striking feature of our model, which is supported by mutagenesis experiments, is that nearly all of the disease mutations map to the domain interface. The simulations indicate that the kinase domain is stabilized in an inactive state by the pseudokinase domain, and they offer a molecular rationale for the hyperactivity of V617F, the predominant JAK2 MPN mutation.

UI MeSH Term Description Entries
D008957 Models, Genetic Theoretical representations that simulate the behavior or activity of genetic processes or phenomena. They include the use of mathematical equations, computers, and other electronic equipment. Genetic Models,Genetic Model,Model, Genetic
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures
D053614 Janus Kinase 2 A Janus kinase subtype that is involved in signaling from GROWTH HORMONE RECEPTORS; PROLACTIN RECEPTORS; and a variety of CYTOKINE RECEPTORS such as ERYTHROPOIETIN RECEPTORS and INTERLEUKIN RECEPTORS. Dysregulation of Janus kinase 2 due to GENETIC TRANSLOCATIONS have been associated with a variety of MYELOPROLIFERATIVE DISORDERS. JAK-2 Protein Tyrosine Kinase,JAK2 Protein Tyrosine Kinase,JAK 2 Protein Tyrosine Kinase

Related Publications

Yibing Shan, and Kavitha Gnanasambandan, and Daniela Ungureanu, and Eric T Kim, and Henrik Hammarén, and Kazuo Yamashita, and Olli Silvennoinen, and David E Shaw, and Stevan R Hubbard
April 2003, Molecular biology of the cell,
Yibing Shan, and Kavitha Gnanasambandan, and Daniela Ungureanu, and Eric T Kim, and Henrik Hammarén, and Kazuo Yamashita, and Olli Silvennoinen, and David E Shaw, and Stevan R Hubbard
May 2000, Molecular and cellular biology,
Yibing Shan, and Kavitha Gnanasambandan, and Daniela Ungureanu, and Eric T Kim, and Henrik Hammarén, and Kazuo Yamashita, and Olli Silvennoinen, and David E Shaw, and Stevan R Hubbard
March 2003, Cell,
Yibing Shan, and Kavitha Gnanasambandan, and Daniela Ungureanu, and Eric T Kim, and Henrik Hammarén, and Kazuo Yamashita, and Olli Silvennoinen, and David E Shaw, and Stevan R Hubbard
March 1996, Cell,
Yibing Shan, and Kavitha Gnanasambandan, and Daniela Ungureanu, and Eric T Kim, and Henrik Hammarén, and Kazuo Yamashita, and Olli Silvennoinen, and David E Shaw, and Stevan R Hubbard
July 2004, The Journal of biological chemistry,
Yibing Shan, and Kavitha Gnanasambandan, and Daniela Ungureanu, and Eric T Kim, and Henrik Hammarén, and Kazuo Yamashita, and Olli Silvennoinen, and David E Shaw, and Stevan R Hubbard
September 2001, Cell,
Yibing Shan, and Kavitha Gnanasambandan, and Daniela Ungureanu, and Eric T Kim, and Henrik Hammarén, and Kazuo Yamashita, and Olli Silvennoinen, and David E Shaw, and Stevan R Hubbard
March 2020, Nature chemical biology,
Yibing Shan, and Kavitha Gnanasambandan, and Daniela Ungureanu, and Eric T Kim, and Henrik Hammarén, and Kazuo Yamashita, and Olli Silvennoinen, and David E Shaw, and Stevan R Hubbard
June 2014, Proceedings of the National Academy of Sciences of the United States of America,
Yibing Shan, and Kavitha Gnanasambandan, and Daniela Ungureanu, and Eric T Kim, and Henrik Hammarén, and Kazuo Yamashita, and Olli Silvennoinen, and David E Shaw, and Stevan R Hubbard
June 2007, Cell,
Yibing Shan, and Kavitha Gnanasambandan, and Daniela Ungureanu, and Eric T Kim, and Henrik Hammarén, and Kazuo Yamashita, and Olli Silvennoinen, and David E Shaw, and Stevan R Hubbard
October 2014, The Journal of biological chemistry,
Copied contents to your clipboard!